Welcome to LookChem.com Sign In|Join Free

CAS

  • or

887147-19-5

Post Buying Request

887147-19-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

887147-19-5 Usage

General Description

4,6-dichloro-1-Methyl-1H-iMidazo[4,5-c]pyridine is a chemical compound that belongs to the class of imidazopyridines. It has a molecular formula of C8H6Cl2N2 and a molecular weight of 199.05 g/mol. 4,6-dichloro-1-Methyl-1H-iMidazo[4,5-c]pyridine is a heterocyclic organic compound that contains both imidazole and pyridine rings. It is often used as a building block in the synthesis of pharmaceutical compounds and agrochemicals. Its structure and properties make it suitable for various applications in the field of medicinal chemistry and drug discovery. Additionally, it has been found to exhibit biological activity, making it a potential candidate for the development of new therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 887147-19-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,1,4 and 7 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 887147-19:
(8*8)+(7*8)+(6*7)+(5*1)+(4*4)+(3*7)+(2*1)+(1*9)=215
215 % 10 = 5
So 887147-19-5 is a valid CAS Registry Number.

887147-19-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,6-Dichloro-1-methyl-1H-imidazo[4,5-c]pyridine

1.2 Other means of identification

Product number -
Other names 4,6-dichloro-1-methylimidazo[4,5-c]pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:887147-19-5 SDS

887147-19-5Relevant articles and documents

Synthesis and evaluation of novel imidazo[4,5-: C] pyridine derivatives as antimycobacterial agents against Mycobacterium tuberculosis

Madaiah, Malavalli,Prashanth, Maralekere K.,Revanasiddappa, Hosakere D.,Veeresh, Bantal

, p. 9194 - 9204 (2016/11/11)

The current study involves the synthesis of novel imidazo[4,5-c]pyridine derivatives (IPD) containing amide/urea/sulfonamide. The synthesized compounds were evaluated for in vitro and in vivo antimycobacterial activities against Mycobacterium tuberculosis. The pharmacological activities were determined by the objective to better understand their structure-activity relationship (SAR) for their in vitro antimycobacterial activity against M. tuberculosis. Some synthesized compounds showed significant activity against M. tuberculosis based on the agar dilution method. Among the forty-one compounds screened, compounds 21, 22 and 23 were found to be the most active compounds against M. tuberculosis. In the in vivo animal model, 21, 22 and 23 decreased the bacterial load in lung and spleen tissues at the dose of 50 mg kg-1 body weight.

ALKYNYL ALCOHOLS AND METHODS OF USE

-

Page/Page column 138; 139, (2015/03/13)

The invention relates to compounds of Formula (0): wherein A1-A8, R4 and R5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.

1, 6 -DIHYDRO- 1,3, 5, 6-TETRAAZA-AS-INDACENE BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AS INHIBITORS OF IKK ENZYME ACTIVITY

-

Page/Page column 74, (2010/11/24)

The present invention provides for tricyclic compounds having the formula (I) wherein R1, R2, R5, R6, R7, and R8 are as described herein. The present invention further provides pharmaceutical compositions comprising such compounds, as well as the use of such compounds for treating inflammatory and immune diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 887147-19-5